CLINICAL_TRIALS
trial_result
· 2016-05-26
Clinical Trial Update: Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults [Phase 3]
Summary
DiaPep277 Phase 3 efficacy and safety trial in newly diagnosed adults with Type 1 Diabetes Mellitus has completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Andromeda Biotech Ltd. | Conditions: Type 1 Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2016-05-26